-
101
A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes
Published 2022-01-01“…In LUAD patients, the strong connection between the risk score and overall survival was further verified in three other GEO data sets. TMB and cancer stem cell infiltration were shown to be significantly higher in the high-risk group in comparison to the low-risk group. …”
Get full text
Article -
102
Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women
Published 2025-01-01“…Moreover, MHT is associated with cell proliferation and mutation signaling pathways in breast cancer, as well as the process of growing the breast cancer stem cell. …”
Get full text
Article -
103
Evaluating the role of CD44 in oral squamous cell carcinoma and potentially malignant disorders – An immunohistochemical study
Published 2024-06-01“…Oral submucous and leukoplakia are examples of potentially malignant disorders (PMDs) that are signs of the preclinical stage of oral cancerCD44 (Cluster of differentiation) is a cell surface glycoprotein that serves as a Cancer Stem Cell marker. Aim: The purpose of the study was to look at the presence of CD44 immunohistochemically in oral epithelial dysplasia, oral submucous fibrosis, and OSCC and how it influences a patient's prognosis. …”
Get full text
Article -
104
The AhR pathway regulation in phthalates-induced cancer promotion, progression and metastasis: a scoping review
Published 2025-01-01“…Specifically, DEHP activated AhR, leading to elevated expression of EMT markers, increased cancer stem cell populations, and enhanced drug metabolism and resistance. …”
Get full text
Article -
105
Developing novel Lin28 inhibitors by computer aided drug design
Published 2025-01-01“…Abstract Lin28 is a key regulator of cancer stem cell gene network that promotes therapy-resistant tumor progression in various tumors. …”
Get full text
Article -
106
The endonuclease activity of MCPIP1 controls the neoplastic transformation of epithelial cells via the c-Met/CD44 axis
Published 2025-01-01“…We observed that either expression downregulation or mutation of MCPIP1 significantly increased its clonogenicity and altered the expression of cancer stem cell (CSC) markers and factors involved in epithelial-to-mesenchymal transition (EMT). …”
Get full text
Article -
107
MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T...
Published 2023-01-01“…Significant positive correlations were found with DC versus cancer stem cells (p=0.008) and the expression of MMP9 versus cancer stem cells (p=0.018). …”
Get full text
Article -
108
Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma
Published 2025-02-01“…Elevated expression of TFF3 promoted the oncogenicity of ER+HER2+ MC cells, including enhanced cell proliferation, survival, anchorage-independent growth, 3D growth, cancer stem cell-like (CSC-like) phenotype, migration, invasion, and xenograft growth. …”
Get full text
Article -
109
GADD45β Determines Chemoresistance and Invasive Growth of Side Population Cells of Human Embryonic Carcinoma
Published 2010-01-01“…NEC8 SP cells showed characteristics of cancer stem cells, such as high growth rate, chemoresistance and high invasiveness. …”
Get full text
Article -
110
Circ_0044516 Regulates miR-136/MAT2A Pathway to Facilitate Lung Cancer Development
Published 2021-01-01“…We also found that cancer stem cell properties were restrained by silencing circ_0044516 in A549 and SPC-A1 cells. …”
Get full text
Article -
111
ZEB1 as a marker of metastasis in thyroid carcinomas: review of literature and own data
Published 2024-11-01“…Since ZEB1 is a key regulator of EMT, metastasizing is associated with cancer stem cell formation and resistance to therapy in many cancers, including papillary thyroid carcinoma. …”
Get full text
Article -
112
Vernolactone Promotes Apoptosis and Autophagy in Human Teratocarcinomal (NTERA-2) Cancer Stem-Like Cells
Published 2019-01-01“…The present study was designed to determine antiproliferative, apoptotic, autophagic, and antioxidant effects of vernolactone, isolated from V. zeylanica, in human embryonal carcinoma cells (NTERA-2, a cancer stem cell model). Antiproliferative effects of vernolactone in NTERA-2 cells and human peripheral blood mononuclear cells (control cells) were evaluated using the Sulforhodamine B (SRB) assay and WST-1 antiproliferative assays, respectively. …”
Get full text
Article -
113
Construction and validation of prognosis and treatment outcome models based on plasma membrane tension characteristics in bladder cancer
Published 2025-01-01“…Higher scores were characterized by lower cancer stem cell (CSC) indices, as well as higher tumor microenvironment (TME) stromal and immune scores, suggesting that high scores were associated with poorer prognosis. …”
Get full text
Article -
114
D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint
Published 2025-01-01Get full text
Article -
115
“Subtype-precise” therapy leads diagnostic and therapeutic innovations: a new pattern for precision treatment of breast cancer
Published 2024-11-01“…They deeply analyzed the molecular characteristics of TNBC, leading to the development of a “Fudan subtype” closely related to clinical outcomes: luminal androgen receptor subtype (LAR), which can be targeted with anti-HER2 and CDK4/6 inhibitors; the immunomodulatory subtype (IM), suitable for immunotherapy; basal-like immune-suppressed subtype (BLIS), which can be treated with platinum-based drugs or poly (ADP-ribose) polymerase (PARP) inhibitors; and mesenchymal-like subtype (MES), which can be treated with anti-cancer stem cell and anti-angiogenic therapies. The team then extended the concept of “subtype-precise” to luminal breast cancer, the subtype with the largest number, the highest proportion and the risk of recurrence for decades. …”
Get full text
Article -
116
Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma
Published 2017-01-01“…Among the cellular heterogeneity of tumors, the existence of a small fraction of cells called cancer stem cells (CSC), thought to be responsible for the onset and propagation of cancer, has been demonstrated in some neoplasia. …”
Get full text
Article -
117
Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer
Published 2025-01-01“…The correlations of UCK2 with prognosis, genetic instability, DNA repair, cancer stem cell characteristics, and immune cell infiltration were investigated. …”
Get full text
Article -
118
Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
Published 2016-01-01“…Expression of a cancer stem cell marker, LGR5 in tumor organoids, was higher than that in primary tumor tissues. …”
Get full text
Article -
119
Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells
Published 2019-01-01“…Targeting AA metabolism helps inhibit the stemness of cancer stem cells and remodels the function of normal stem cells. …”
Get full text
Article -
120
Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update
Published 2016-01-01“…Cancer originates from genetic mutations accumulation. Cancer stem cells have been depicted as tumorigenic cells that can differentiate and self-renew. …”
Get full text
Article